Comment on “Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review”
Main Authors: | Todtenkopf Mark S. PhD, Correll Christoph U. MD, Harris-White Marni E. PhD, Doane Michael J. PhD, McDonnell David MD |
---|---|
Format: | Article |
Language: | English |
Published: |
American Association of Psychiatric Pharmacists
2023-08-01
|
Series: | Mental Health Clinician |
Online Access: | https://theijpt.org/doi/pdf/10.9740/mhc.2023.08.196 |
Similar Items
-
Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review
by: S. Andrea Laguado, PharmD, BCPS, BCPP, et al.
Published: (2023-08-01) -
Inhaled opioids for cancer pain relief
by: Magdalena Osowicka, MD, PhD, et al.
Published: (2022-06-01) -
Effects of Mineralocorticoid Receptor Antagonists in Early-Stage Heart Failure With Preserved Ejection Fraction
by: Kazuki Kagami, MD, et al.
Published: (2023-05-01) -
Comment on The Unbearable Lightness of Difference Between Statistical and Clinical Significance
by: Luca Bertolaccini, MD, PhD, FCCP, et al.
Published: (2022-03-01) -
Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix
by: Kristof Chwalisz, M.D., Ph.D.
Published: (2023-06-01)